Kawasaki Disease (Conjunctival Redness)
What is Kawasaki Disease (Conjunctival Redness)?
Kawasaki disease (KD) is an acute, self‑limited vasculitis that primarily affects children under five years of age. One of the hallmark findings is a painless, bright‑red “conjunctival injection” (also called conjunctival redness) that involves both eyes without any discharge or crusting. The redness results from inflammation of the small blood vessels in the conjunctiva and is one of the six principal clinical criteria used to diagnose KD.
Although the exact trigger remains unknown, the disease can lead to serious complications—most notably coronary artery aneurysms—if not recognized and treated promptly. Early identification of conjunctival redness together with other symptoms allows clinicians to start therapy within the critical 10‑day window, dramatically reducing the risk of heart problems.
Common Causes
Conjunctival redness is not unique to Kawasaki disease; many other conditions can produce a similar appearance. Below are 8–10 of the most frequent causes that clinicians consider when evaluating a child with red eyes.
- Viral conjunctivitis – adenovirus, enterovirus, or herpes simplex virus.
- Bacterial conjunctivitis – Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae.
- Allergic conjunctivitis – pollen, pet dander, or dust mite exposure.
- Uveitis – inflammation of the uveal tract, often associated with autoimmune disease.
- Blepharitis – inflammation of the eyelid margins leading to secondary redness.
- Trauma or foreign body – mechanical irritation that can cause a localized injection.
- Chemical splash or irritant exposure – chlorine, smoke, or industrial chemicals.
- Systemic vasculitides – e.g., polyarteritis nodosa or Henoch‑Schönlein purpura.
- Medication side‑effects – topical prostaglandin analogues for glaucoma, certain antibiotics.
- Systemic infections with rash – measles, erythema infectiosum (parvovirus B19), or scarlet fever.
Associated Symptoms
In Kawasaki disease, conjunctival redness almost always appears with a constellation of other findings. Recognizing the full pattern is essential for a correct diagnosis.
- Fever lasting ≥5 days – typically high (≥39°C/102.2°F) and unresponsive to ordinary antipyretics.
- Oral mucosal changes – strawberry‑like tongue, cracked lips, or diffuse erythema of the oral cavity.
- Extremity changes – swelling, erythema, and later desquamation (peeling) of the hands and feet.
- Polymorphous rash – may be maculopapular, scarlatiniform, or erythema multiforme‑like.
- Cervical lymphadenopathy – usually a single node >1.5 cm in diameter.
- Irritability or lethargy – especially in infants.
- Cardiac involvement – murmur, gallop rhythm, or signs of myocarditis (later in the disease).
When conjunctival redness occurs without fever or the other KD criteria, clinicians usually look for alternative diagnoses such as viral or allergic conjunctivitis.
When to See a Doctor
Because untreated Kawasaki disease can lead to permanent heart damage, prompt medical attention is vital. Seek care if any of the following are present:
- Fever lasting more than 24–48 hours in a child under 5 years, especially with red eyes.
- Redness in both eyes without discharge, crusting, or itching.
- Any combination of fever, rash, swollen hands/feet, cracked lips, or a swollen neck node.
- Sudden onset of eye redness after a known viral illness that does not improve within 2–3 days.
- Signs of eye pain, blurred vision, photophobia, or fluid leaking from the eye.
If you are unsure, err on the side of caution and have the child evaluated by a pediatrician or pediatric emergency department.
Diagnosis
There is no single laboratory test that confirms Kawasaki disease; diagnosis is clinical, supported by laboratory and imaging studies.
Clinical Evaluation
- Complete history (duration of fever, exposure to sick contacts, medication use).
- Thorough physical exam focusing on the six KD criteria listed above.
Laboratory Tests
- Complete blood count (CBC) – typically shows neutrophilia, anemia, and occasionally thrombocytosis after day 7.
- Inflammatory markers – elevated C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
- Liver enzymes – mild transaminitis is common.
- Urinalysis – may reveal sterile pyuria (white cells without bacteria).
- Serologies – used to exclude infectious mimics (e.g., adenovirus, parvovirus B19).
Cardiac Imaging
- Echocardiogram – the cornerstone test; performed at diagnosis, 2 weeks, and 6–8 weeks to assess coronary arteries and ventricular function.
- Electrocardiogram (ECG) – helps detect arrhythmias or ischemic changes.
Ophthalmologic Examination
A slit‑lamp exam can confirm that the conjunctival injection is non‑purulent, bilateral, and without follicular or papillary reaction—findings that point toward KD rather than infectious conjunctivitis.
Treatment Options
Rapid initiation of therapy dramatically reduces the incidence of coronary artery aneurysms from ~25% to <5%.
First‑Line Medical Therapy
- Intravenous Immunoglobulin (IVIG) – 2 g/kg given over 10–12 hours, ideally within the first 10 days of fever.
- Aspirin – high‑dose (80–100 mg/kg/day) in the acute phase until the fever resolves, then low‑dose (3–5 mg/kg/day) for antiplatelet effect, continued for 6–8 weeks or longer if coronary changes persist.
Adjunctive Therapies
- Corticosteroids – indicated for IVIG‑resistant disease or in high‑risk patients (e.g., infants <1 year, high CRP).
- Infliximab or other anti‑TNF agents – used for refractory cases when IVIG and steroids fail.
- Additional IVIG doses – a second infusion may be administered if fever persists >36 hours after the first dose.
Supportive & Home Care
- Maintain adequate hydration; fever can increase fluid loss.
- Use acetaminophen for comfort if aspirin is contraindicated (e.g., active bleeding).
- Monitor temperature at home; keep a log to share with the physician.
- Encourage rest and avoid vigorous activities while the heart is being evaluated.
Follow‑Up
All children with KD need repeat echocardiograms. Those with normal coronary arteries typically have imaging at 2 weeks and 6–8 weeks; abnormal findings may require lifelong cardiology follow‑up.
Prevention Tips
Because the exact cause of Kawasaki disease is unknown, true primary prevention is not possible. However, certain measures can help reduce the risk of complications and improve outcomes:
- Promptly seek medical evaluation for any child with fever ≥5 days plus eye redness or rash.
- Vaccinate according to the recommended schedule—while vaccines do not prevent KD, they protect against infections that can mimic or trigger similar inflammatory responses.
- Practice good hand hygiene and avoid close contact with individuals who have active viral conjunctivitis.
- Ensure children with known KD receive scheduled cardiology appointments and adhere to prescribed aspirin therapy.
- Educate caregivers about the signs of coronary artery problems (chest pain, shortness of breath, palpitations) for early detection.
Emergency Warning Signs
If any of the following occur, go to the nearest emergency department or call emergency services (911 in the U.S.) immediately:
- Sudden chest pain, pressure, or tightness.
- Rapid or irregular heartbeat (palpitations, skipped beats).
- Shortness of breath or difficulty breathing.
- Severe, persistent vomiting or inability to keep fluids down.
- Signs of shock – pale, clammy skin; fainting; extreme lethargy.
- Rapid swelling of the hands, feet, or face with pain.
Key Take‑aways
Kawasaki disease is a pediatric vasculitis whose classic presentation includes bright, painless conjunctival redness in both eyes. Recognizing this sign together with prolonged fever, oral changes, extremity swelling, rash, and lymphadenopathy allows for early treatment with IVIG and aspirin, which dramatically lowers the risk of coronary artery aneurysms. Parents and caregivers should act quickly when the characteristic pattern appears and should never hesitate to seek urgent care if cardiac or systemic warning signs develop.
References
- Mayo Clinic. Kawasaki disease. https://www.mayoclinic.org/diseases-conditions/kawasaki-disease/diagnosis-treatment
- American Heart Association. Management of Kawasaki Disease. 2023. https://www.heart.org/en/health-topics/kawasaki-disease
- Centers for Disease Control and Prevention. Kawasaki Disease. https://www.cdc.gov/kawasaki/
- National Institutes of Health. Kawasaki Disease (PDQ®) Health Professional Version. https://www.ncbi.nlm.nih.gov/books/NBK448053/
- Cleveland Clinic. Kawasaki disease in children. https://my.clevelandclinic.org/health/diseases/17339-kawasaki-disease
- World Health Organization. International Guidelines for the Diagnosis and Management of Kawasaki Disease. 2022.